New drug trial targets root cause of severe COPD Flare-Ups

This study tested whether a drug called mepolizumab could help control a specific type of chronic obstructive pulmonary disease (COPD). It focused on COPD patients whose lungs have high levels of a specific inflammatory cell called an eosinophil, which is linked to severe symptom flare-ups. The goal was to see if this targeted drug could reduce these cells and flare-ups, potentially offering an alternative to steroids, which have significant side effects.